About the Sweeney Lab

Our multidisciplinary research program spans molecular and cellular analyses, integrative physiology approaches for preclinical phenotyping, clinical and drug discovery studies. It is focused on obesity, diabetes & heart failure (cardiometabolic disease: CMD), particularly with a focus on adiponectin, and designed to:

a) implement & conduct innovative basic research to uncover novel mechanisms of CMD.

b) identify & develop transformative strategies for discovering

i) innovative biomarkers which confer early & accurate risk prediction;

ii) novel, effective & safe therapeutic intervention.

Our Team

Dr. Sweeney has been invited to give annual presentations at international conferences such as the Heart Failure Society of America, European Association for the Study of Diabetes, International Society for Heart Research, Society for Heart & Vascular Metabolism, American College Cardiology as well as at national and international academic institutions.

Trainees have consistently earned outstanding recognitions, such as:

Euro Congress of Endocrinology: abstract & oral presentation selected as one of four prize winners from over 1,000 abstracts;
Mitacs Globalink Awards
Society for Heart & Vascular Metabolism: Best Young Investigator Award
Fellowships & Studentships from CIHR, the Canadian Diabetes Association, and the Heart & Stroke Foundation

Dr. Sweeney is also regularly invited to serve on peer review panels, including in roles such as:

CIHR, committee member and Scientific Officer
Canadian Diabetes Association, reviewer for grant and personnel committees
Heart & Stroke Foundation, grant review committee
FRSQ, review committee chair

In addition, he has held many editorial positions including:

Diabetes, Consulting editor
American Journal of Physiology: Endocrinology & Metabolism, Editorial Board Member
Frontiers in Cellular Endocrinology, Associate editor
Several additional editorial appointments